Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | IKBKB | O14920 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20553824 | 0.98 | GPR3 (0.52) | GPR3MAPTALDH1A1RAB9AHPGD | |
| SCHEMBL22620062 | 0.84 | KDM4E (0.46) | GPR3MAPTALDH1A1RAB9AHPGD | |
| SCHEMBL16668988 | 0.84 | GPR3 (0.33) | GPR3 | |
| SCHEMBL1335902 | 0.80 | GPR3 (0.32) | GPR3 | |
| SCHEMBL28512782 | 0.79 | ALDH1A1 (0.33) | GPR3MAPTALDH1A1RAB9AHPGD | |
| SCHEMBL28634113 | 0.77 | KDM4E (0.34) | GPR3ALDH1A1HPGDSMN1; SMN2IKBKB | |
| Dibenzothiophene SCHEMBL28979299 | 0.75 | GPR3 (0.93) | GPR3MAPTALDH1A1RAB9AHPGD | |
| Dibenzothiophene SCHEMBL28979048 | 0.75 | GPR3 (0.93) | GPR3MAPTALDH1A1RAB9AHPGD | |
| Dibenzothiophene SCHEMBL28979045 | 0.75 | GPR3 (0.93) | GPR3MAPTALDH1A1RAB9AHPGD | |
| Dibenzothiophene SCHEMBL27489159 | 0.75 | GPR3 (0.93) | GPR3MAPTALDH1A1RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 823 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118284595-A | Arylamine compound, organic electroluminescent element, and electronic device | 保土谷化学工业株式会社 | 2024-07-02 | — | — | CN | claimed |
| WO-2024121084-A1 | PREPARATION OF NITRILES | MERCK PATENT GMBH (DE) | 2024-06-13 | — | — | WO | claimed |
| CN-117756767-A | Preparation method of gamma, gamma-difluoroallylaldehyde compound and derivative thereof | 南京林业大学 | 2024-03-26 | — | — | CN | claimed |
| EP-3749631-B1 | TRIARYLMETHANE COMPOUNDS | MITSUBISHI GAS CHEMICAL CO (JP) | 2024-03-06 | — | — | EP | claimed |
| US-11917906-B2 | Compounds that can be used in an organic electronic device | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | claimed |
| CN-117466947-A | Binuclear platinum complexes for OLED applications | 香港大学 | 2024-01-30 | — | — | CN | claimed |
| US-20230391704-A1 | TRIARYLMETHANE COMPOUNDS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-12-07 | — | — | US | claimed |
| CN-116854599-A | Tetraphenyl ethylene derivative and organic electroluminescent device comprising same | 广东省大湾区华南理工大学聚集诱导发光高等研究院 | 2023-10-10 | — | — | CN | claimed |
| WO-2023095844-A1 | ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 保土谷化学工業株式会社 | 2023-06-01 | — | — | WO | claimed |
| CN-108129431-B | Fluorenonaphthofuran derivative and application thereof | 北京鼎材科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| US-5607926-A | ACTIVE AGAINST METHICILLIN RESISTANT BACTERIA | MICROCIDE PHARMACEUTICALS, INC. (US) | 1997-03-04 | — | — | US | claimed |
| EP-0754184-A1 | CEPHALOSPORIN ANTIBIOTICS | Microcide Pharmaceuticals, Inc. (US) | 1997-01-22 | — | — | EP | claimed |
| WO-1995026966-A1 | CEPHALOSPORIN ANTIBIOTICS | MICROCIDE PHARMACEUTICALS, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| US-5254546-A | Hypotensive agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-10-19 | — | — | US | claimed |
| EP-0524946-A4 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | — | 1993-03-24 | — | — | EP | claimed |
| EP-0524946-A1 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-03 | — | — | EP | claimed |
| EP-0479892-A1 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-15 | — | — | EP | claimed |
| WO-1991015206-A1 | TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-17 | — | — | WO | claimed |
| WO-1991014367-A1 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-03 | — | — | WO | claimed |
| WO-1991000281-A2 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391704-A1 | TRIARYLMETHANE COMPOUNDS | CBR3, HAX1, HRH3 | GPR3 236/4885MAPT 4486/4885ALDH1A1 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.